EU device industry competitiveness update in mid-November:
This article was originally published in Clinica
Executive Summary
The European Commission steering group that is working on the report on the competitiveness of the medical device industry is holding its next meeting on November 15 to review comments that have been made on the first draft report. The purpose of this E100,000 ($116,000) study is to gather data in relation to economic and industrial features of the medical devices industry in Europe, the impact on health and public expenditure, and the global competitiveness of the European medical devices industry. This study was recognised as being urgently needed in the context of the five-year review of the Medical Devices Directive and the Commission has made it clear that it now wishes to set a precedent with this study, ensuring that its data-collection initiatives remain in place for future information and analysis.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.